Wire Stories

Everen Limited (formerly Oil Insurance Limited) reveals its brand identity

HAMILTON, Bermuda--(BUSINESS WIRE)--Following a rebranding announcement, Everen reveals its brand-new visual identity. The new logo and elements of the brand…

3 years ago

Australian Red Cross Taps Boomi to Help Raise $27M For Flood-affected Communities

Boomi provides data connectivity and technical support to ensure success of the recent Australia Unites Telethon Following recent wins in…

3 years ago

DL E&C to Advance to Global Market Using Korea-Developed CCUS Technologies

- DL E&C signed an MOU with KEPCO KEPRI to establish a mutual exchange of technology and collaboration system. -…

3 years ago

NEW YORK & LONDON & MUMBAI, India--(BUSINESS WIRE)--$WNS #AWS--WNS (Holdings) Limited (NYSE: WNS), a leading provider of global Business Process…

3 years ago

Enfusion Appoints Oleg Movchan Interim Chief Executive Officer

Reiterates 2022 Third Quarter and Full Year Revenue Guidance NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE:…

3 years ago

Mobile Devices Markets in China: Demand to Grow at 10% Yearly Through 2031 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Mobile Devices Markets in China" report has been added to ResearchAndMarkets.com's offering. China's demand for Mobile Devices has…

3 years ago

Lenovo Evolves Small Businesses

RALEIGH, N.C.--(BUSINESS WIRE)--Today, Lenovo announced the new iteration of Evolve Small � an initiative built to champion and promote small…

3 years ago

Alkegen Announces Plans to Increase Micro-Fine Glass Fiber Capacity To Support Growing Battery and Filtration Demand

Company expanding micro-fine glass fiber capacity in US, Europe, and China to support future growth BUFFALO, N.Y.--(BUSINESS WIRE)--Alkegen, one of…

3 years ago

Pillar Biosciences Receives China National Medical Products Administration (NMPA) Approval for oncoRevealTM Dx Colon Cancer Assay

- Highly-accurate, tissue-based, next-generation sequencing (NGS) test approved in China as a companion diagnostic for targeted colon cancer therapies NATICK,…

3 years ago

TOKYO--(BUSINESS WIRE)--Solasia Pharma K.K. (TOKYO:4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter �Solasia�) officially announced today that an…

3 years ago